{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:29Z","timestamp":1787020109883,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2688-y","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:35:56Z","timestamp":1503563756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014)"],"prefix":"10.1186","volume":"17","author":[{"given":"Am\u00f3s","family":"Garc\u00eda-Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gil-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo \u00c1ngel","family":"N\u00fa\u00f1ez-Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Matute-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Gil-de-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"issue":"5","key":"2688_CR1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp048320","volume":"352","author":"M V\u00e1zquez","year":"2005","unstructured":"V\u00e1zquez M, Shapiro ED. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med. 2005;352(5):439\u201340.","journal-title":"N Engl J Med"},{"issue":"11","key":"2688_CR2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archinte.1997.00440320105010","volume":"157","author":"K Galil","year":"1997","unstructured":"Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997;157(11):1209\u201313.","journal-title":"Arch Intern Med"},{"issue":"157","key":"2688_CR3","first-page":"571","volume":"25","author":"RE Hope-Simpson","year":"1975","unstructured":"Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975;25(157):571\u20135.","journal-title":"J R Coll Gen Pract"},{"issue":"23\u201324","key":"2688_CR4","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23\u201324):3076\u201390.","journal-title":"Vaccine"},{"issue":"7264","key":"2688_CR5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","volume":"321","author":"S Helgason","year":"2000","unstructured":"Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000;321(7264):794\u20136.","journal-title":"BMJ"},{"issue":"2","key":"2688_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archderm.1957.01550140037006","volume":"75","author":"JM Moragas De","year":"1957","unstructured":"De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Derm. 1957;75(2):193\u20136.","journal-title":"AMA Arch Derm"},{"issue":"22","key":"2688_CR7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Shingles Prevention Study Group, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"key":"2688_CR8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1086\/315492","volume":"181","author":"F Lin","year":"2000","unstructured":"Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalisations: the pre-vaccination era. J Infect Dis. 2000;181:1897\u2013905.","journal-title":"J Infect Dis"},{"key":"2688_CR9","unstructured":"Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria e Innovaci\u00f3n. Sistema de Informaci\u00f3n Sanitaria del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014. \nhttps:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/sisInfSanSNS\/pdf\/SISNS.pdf\n\n. Accessed 22 Aug 2017."},{"key":"2688_CR10","unstructured":"Rivero Cuadrado A. An\u00e1lisis y desarrollo de los GDR en el Sistema Nacional de Salud. Available: \nhttp:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/docs\/analisis.pdf\n\n. Accessed 22 Aug 2017."},{"key":"2688_CR11","unstructured":"Sevilla F. La universalizaci\u00f3n de la atenci\u00f3n sanitaria. Sistema Nacional de Salud y Seguridad Social. Fundaci\u00f3n Alternativas. Documento de trabajo 86\/2006. \nhttp:\/\/www.seg-social.es\/prdi00\/groups\/public\/documents\/binario\/51587.pdf\n\n. Accessed 22 Aug 2017."},{"key":"2688_CR12","unstructured":"Ministerio de Sanidad y Consumo. Clasificaci\u00f3n Internacional de Enfermedades 9\u00aa revisi\u00f3n, modificaci\u00f3n cl\u00ednica. (\nhttp:\/\/www.msc.es\/estadEstudios\/estadisticas\/normalizacion\/clasifEnferm\/home.htm\n\n) (Accessed September 2016)."},{"key":"2688_CR13","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1097\/MD.0000000000000831","volume":"94","author":"R Gil-Prieto","year":"2015","unstructured":"Gil-Prieto R, Gonzalez-Escalada A, Mar\u00edn-Garc\u00eda P, Gallardo-Pino C, Gil-de-Miguel A. Respiratory Syncytial virus Bronchiolitis in children up to 5 years of age in Spain: epidemiology and comorbidities: an observational study. Medicine (Baltimore). 2015;94:e831.","journal-title":"Medicine (Baltimore)"},{"key":"2688_CR14","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/all.12613","volume":"70","author":"MA Tejedor-Alonso","year":"2015","unstructured":"Tejedor-Alonso MA, Moro-Moro M, Mosquera Gonz\u00e1lez M, Rodriguez-Alvarez M, P\u00e9rez Fern\u00e1ndez E, Latasa Zamalloa P, et al. Increased incidence of admissions for anaphylaxis in Spain 1998\u20132011. Allergy. 2015;70:880\u20133.","journal-title":"Allergy"},{"key":"2688_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","volume":"9","author":"A Gil","year":"2009","unstructured":"Gil A, Gil R, Alvaro A, San Mart\u00edn M, Gonz\u00e1lez A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis. 2009;9:55.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2688_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","volume":"32","author":"R Gil-Prieto","year":"2014","unstructured":"Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Mar\u00edn-Garc\u00eda P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014;32(2):277\u201383. doi:\nhttps:\/\/doi.org\/10.1016\/j.vaccine.2013.11.008\n\n. Epub 2013 Nov 22","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"2688_CR17","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","volume":"70","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ. Epidemiology of Varicella-zoster virus in England and Wales. J Med Virol. 2003;70(Suppl 1):S9\u201314.","journal-title":"J Med Virol"},{"issue":"4","key":"2688_CR18","first-page":"282","volume":"3","author":"JC Bramley","year":"2000","unstructured":"Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000;3(4):282\u20137.","journal-title":"Commun Dis Public Health"},{"key":"2688_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00013542-199310000-00006","volume":"4","author":"E Miller","year":"1993","unstructured":"Miller E, Marshall R, Verdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993;4:222\u201330.","journal-title":"Rev Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:36:10Z","timestamp":1503563770000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2688-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2688-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]},"article-number":"586"}}